Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04177199Unknown

What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?

Role: collaborator

NCT04485624Completed

Vaccination Coverage Amongst Children/Young People Attending the PED

Role: collaborator

NCT03497585Completed

Developing an Activity Pacing Framework: Feasibility and Acceptability

Role: lead

NCT01795833Not ApplicableCompleted

Diabetes Prevention Using SMS Technology

Role: collaborator

NCT02579070Not ApplicableCompleted

Diabetic Foot Ulcer Prevention System (DFUPS) - Part 2

Role: collaborator

NCT03494998Unknown

Refining and Testing the Diagnostic Accuracy of PAT-POPS

Role: lead

NCT02317835Phase 1Completed

Diabetic Foot Ulcer Prevention System

Role: collaborator

NCT01329952Unknown

Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

Role: lead

NCT00792389Phase 4Unknown

Study of the Use of Humidified Warmed Gas and the Effect on Post-Operative Pain in Laparoscopic Cholecystectomies

Role: lead

All 9 trials loaded